59.61
2.42%
-1.48
시간 외 거래:
59.61
Halozyme Therapeutics Inc (HALO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
14.85%
195.88
|
230.04 | 216.03 | 221.04 | 162.14 |
Cost Of Revenue |
45.83%
28.33
|
52.30 | 54.82 | 50.07 | 35.17 |
Gross Profit |
5.73%
167.55
|
177.74 | 161.21 | 170.97 | 126.97 |
Operating Expenses
|
6.12%
72.01
|
76.71 | 72.93 | 76.51 | 73.17 |
Interest Income/Expense |
13.66%
4.507
|
5.22 | 4.505 | 4.494 | 4.543 |
Benefits Costs and Expenses |
22.51%
99.85
|
128.86 | 114.27 | 127.88 | 109.91 |
Costs And Expenses |
22.22%
100.34
|
129.00 | 127.75 | 126.58 | 108.34 |
Operating Income/Loss |
5.44%
95.54
|
101.03 | 88.28 | 94.46 | 53.80 |
Income/Loss From Continuing Operations Before Tax |
5.09%
96.03
|
101.17 | 101.76 | 93.16 | 52.24 |
Income Tax Expense/Benefit |
21.65%
19.20
|
15.79 | 19.92 | 18.40 | 12.62 |
Income/Loss From Continuing Operations After Tax |
10.03%
76.82
|
85.39 | 81.84 | 74.75 | 39.62 |
Net Income/Loss
|
10.03%
76.82
|
85.39 | 81.84 | 74.75 | 39.62 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
13,200%
126.94
|
-0.969 | 131.97 | 131.73 | 135.03 |
Diluted Average Shares |
12,541%
128.89
|
-1.036 | 134.08 | 133.54 | 137.90 |
Basic Earnings Per Share |
6.15%
0.61
|
0.65 | 0.62 | 0.57 | 0.29 |
Diluted Earnings Per Share |
7.69%
0.60
|
0.65 | 0.61 | 0.56 | 0.29 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):